Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate
Manuscript highlights development of robust responses to both influenza and COVID-19 and protection against the SARS-CoV-2 ...
Read more
Tag: Novavax
Novavax COVID-19 Vaccine Demonstrates Efficacy Against the South Africa Variant
Publication of initial primary analysis highlights NVX-CoV2373 cross-protection against B.1.351 variant prevalent in South Africa during ...
Read more
Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine
PREVENT-19 clinical trial expanded to assess the efficacy, safety and immunogenicity of NVX-CoV2373 for the prevention ...
Read more
Sanofi to manufacture Moderna COVID-19 Vaccine in the U.S.
Moderna, Inc. today announced that it has entered into an agreement with Sanofi for fill/finish sterile manufacturing ...
Read more
Novavax publishes Phase 2b Clinical Trial Results of Malaria Vaccine
Vaccine candidate demonstrates high efficacy at 77% in a study of children aged 5-17 months conducted ...
Read more
Novavax to Participate in Oxford Study Comparing Mixed COVID-19 Vaccine Combinations
Novavax, Inc. announced its participation in a newly expanded investigator-initiated Phase 2 clinical trial called Comparing ...
Read more
Moderna and Catalent to Collaborate for Dedicated Vial Filling of Moderna’s COVID-19 Vaccine
Moderna, Inc. and Catalent, Inc. today announced the expansion of their strategic collaboration to dedicate a ...
Read more
Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover
Crossover allows participants to continue in trials and remain blinded Ensures that all trial participants receive ...
Read more
GSK to support manufacture of Novavax’ COVID-19 vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, GSK and the UK ...
Read more